1
|
Li XN, Qi L, Kogiso M, Lindsay HB, Erickson SW, Guo Y, Smith MA, Teicher BA. Pediatric preclinical testing consortium evaluation of the EZH2 inhibitor tazemetostat in orthotopic PDX models of pediatric brain tumors. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.10551] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Xiao-Nan Li
- Laboratory of Molecular Neuro-Oncology, Program of Preclinical Neuro-Oncology Research, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX
| | - Lin Qi
- Laboratory of Molecular Neuro-Oncology, Program of Preclinical Neuro-Oncology Research, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX
| | - Mari Kogiso
- Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
| | - Holly Brianne Lindsay
- Laboratory of Molecular Neuro-Oncology, Program of Preclinical Neuro-Oncology Research, Texas Children’s Cancer Center, Baylor College of Medicine, Houston, TX
| | | | - Yuelong Guo
- RTI International, Research Triangle Park, NC
| | - Malcolm A. Smith
- Cancer Therapy Evaluation Program, National Cancer Institute, Washington, DC
| | - Beverly A. Teicher
- National Cancer Institute at the National Institutes of Health, Bethesda, MD
| |
Collapse
|